Relmada Therapeutics Inc reports results for the quarter ended in June - Earnings Summary

Relmada Therapeutics

08/08/2024 03:08

* Relmada Therapeutics Inc  RLMD.OQ  reported a quarterly
adjusted
loss of 59 cents​​ per share for the quarter ended in June,
higher than the same quarter last year, when the company
reported EPS of -84 cents.  The mean expectation of
four analysts for the quarter was for a loss of 83 cents per
share. Wall Street expected results to range from -87 cents
to -79 cents per share.
    * Reported revenue was zero​; analysts expected zero. 
    * Relmada Therapeutics Inc's reported EPS for the quarter
was a
loss of 59 cents​.
    * The company reported a quarterly loss of $17.77 million.
    * Relmada Therapeutics Inc shares had risen by 8.0% this
quarter and lost 21.7% so far this year.

FORECAST CHANGES
    * The mean earnings estimate of analysts had fallen by
about 1.9%
in the last three months.​ 
    * In the last 30 days, there have been no earnings estimate
revisions by analysts covering the company.

RECOMMENDATIONS
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 2 "strong buy" or "buy," 1
"hold" and 1 "sell" or "strong sell." 
    * The average consensus recommendation for the biotechnology
&
medical research peer group is  "hold."

Wall Street's median 12-month price target for Relmada
Therapeutics Inc is $7.75 
This summary was machine generated from LSEG data August 8 at
02:08 a.m. UTC. ​All figures in US dollars unless otherwise
stated. (For questions concerning the data in this report,
contact Estimates.Support@lseg.com. For any other questions or
feedback, contact RefinitivNewsSupport@thomsonreuters.com) QUARTER ENDING    ESTIMATE       ACTUAL         BEAT, MET,
                                                 MISSED
 Jun. 30 2024      -0.83          -0.59          Beat
 Mar. 31 2024      -0.85          -0.72          Beat
 Dec. 31 2023      -0.83          -0.84          Missed
 Sep. 30 2023      -0.91          -0.73          Beat